REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 480 filers reported holding REPLIGEN CORP in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,326 | +11.5% | 8,339 | -0.8% | 0.00% | +50.0% |
| Q2 2023 | $1,189 | -17.9% | 8,403 | -2.4% | 0.00% | -33.3% |
| Q1 2023 | $1,449 | -1.1% | 8,607 | -0.6% | 0.00% | -25.0% |
| Q4 2022 | $1,465 | -99.9% | 8,655 | -0.9% | 0.00% | 0.0% |
| Q3 2022 | $1,634,000 | +15.5% | 8,735 | +0.2% | 0.00% | 0.0% |
| Q2 2022 | $1,415,000 | -14.8% | 8,715 | -1.3% | 0.00% | 0.0% |
| Q1 2022 | $1,660,000 | -45.3% | 8,827 | -23.0% | 0.00% | -42.9% |
| Q4 2021 | $3,036,000 | -13.8% | 11,465 | -6.0% | 0.01% | -22.2% |
| Q3 2021 | $3,523,000 | +50.0% | 12,192 | +3.6% | 0.01% | +50.0% |
| Q2 2021 | $2,348,000 | -15.7% | 11,767 | -17.9% | 0.01% | -25.0% |
| Q1 2021 | $2,786,000 | +25.6% | 14,332 | +23.7% | 0.01% | +14.3% |
| Q4 2020 | $2,219,000 | +42.9% | 11,583 | +10.0% | 0.01% | +40.0% |
| Q3 2020 | $1,553,000 | +21.9% | 10,532 | +2.2% | 0.01% | 0.0% |
| Q2 2020 | $1,274,000 | – | 10,310 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |